Singular Genomics Systems (OMIC)
NASDAQ:OMIC
US Market

Singular Genomics Systems (OMIC) Stock Price & Analysis

55 Followers

OMIC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.80 - $10.29
Previous Close$2.77
Volume63.23K
Average Volume (3M)130.92K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$263.84M
Total Debt (Recent Filing)$59.05M
Price to Earnings (P/E)-2.2
Beta1.21
Next EarningsMar 01, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-1.25
Shares Outstanding71,396,110
R-Squared0.07
Standard Deviation0.18
10 Day Avg. Volume140,049
30 Day Avg. Volume130,921
Price to Book (P/B)0.65
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside-0.72% Downside
Rating ConsensusHold
Alpha-0.11
Number of Analyst Covering2


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

OMIC FAQ

What was Singular Genomics Systems’s price range in the past 12 months?
Singular Genomics Systems lowest stock price was $1.80 and its highest was $10.29 in the past 12 months.
    What is Singular Genomics Systems’s market cap?
    Currently, no data Available
    When is Singular Genomics Systems’s upcoming earnings report date?
    Singular Genomics Systems’s upcoming earnings report date is Mar 01, 2023 which is in 32 days.
      How were Singular Genomics Systems’s earnings last quarter?
      Singular Genomics Systems released its earnings results on Nov 07, 2022. The company reported -$0.33 earnings per share for the quarter, beating the consensus estimate of -$0.405 by $0.075.
        Is Singular Genomics Systems overvalued?
        According to Wall Street analysts Singular Genomics Systems’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Singular Genomics Systems pay dividends?
          Singular Genomics Systems does not currently pay dividends.
          What is Singular Genomics Systems’s EPS estimate?
          Singular Genomics Systems’s EPS estimate is -$0.42.
            How many shares outstanding does Singular Genomics Systems have?
            Singular Genomics Systems has 71,396,110 shares outstanding.
              What happened to Singular Genomics Systems’s price movement after its last earnings report?
              Singular Genomics Systems reported an EPS of -$0.33 in its last earnings report, beating expectations of -$0.405. Following the earnings report the stock price went down -5.804%.
                Which hedge fund is a major shareholder of Singular Genomics Systems?
                Among the largest hedge funds holding Singular Genomics Systems’s share is Deerfield Management Company, LP. It holds Singular Genomics Systems’s shares valued at 18M.

                  ---

                  Singular Genomics Systems Stock Smart Score

                  The Singular Genomics Systems stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Singular Genomics Systems

                  Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Integrated Solution is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Codexis
                  NanoString Tech
                  Nautilus Biotechnolgy
                  Berkeley Lights
                  Inotiv

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis